These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 1810899)
1. Reduction of proteinuria with captopril therapy in patients with focal segmental glomerulosclerosis and IgA nephropathy. Huissoon AP; Meehan S; Keogh JA Ir J Med Sci; 1991 Oct; 160(10):319-21. PubMed ID: 1810899 [TBL] [Abstract][Full Text] [Related]
2. Evidence from the Oxford Classification cohort supports the clinical value of subclassification of focal segmental glomerulosclerosis in IgA nephropathy. Bellur SS; Lepeytre F; Vorobyeva O; Troyanov S; Cook HT; Roberts IS; Kidney Int; 2017 Jan; 91(1):235-243. PubMed ID: 27914703 [TBL] [Abstract][Full Text] [Related]
3. Effect of the angiotensin converting enzyme inhibitor, captopril, on proteinuria in chronic glomerular disease. Masunaga Y; Tabei K; Takeda S; Ando Y; Kusano E; Asano Y Nihon Jinzo Gakkai Shi; 1993 Aug; 35(8):961-6. PubMed ID: 8255007 [TBL] [Abstract][Full Text] [Related]
4. The renal functional and structural consequences of corticosteroid and angiotensin-converting enzyme inhibitor therapy in chronic puromycin aminonucleoside nephropathy. Trachtman H; Del Pizzo R; Valderrama E; Gauthier B Pediatr Nephrol; 1990 Sep; 4(5):501-4. PubMed ID: 2242316 [TBL] [Abstract][Full Text] [Related]
5. The effects of dual blockade of the renin-angiotensin system on urinary protein and transforming growth factor-beta excretion in 2 groups of patients with IgA and diabetic nephropathy. Song JH; Lee SW; Suh JH; Kim ES; Hong SB; Kim KA; Kim MJ Clin Nephrol; 2003 Nov; 60(5):318-26. PubMed ID: 14640237 [TBL] [Abstract][Full Text] [Related]
6. Effect of captopril on heavy proteinuria in patients with various glomerular diseases. Han DS; Ha SK; Choi KH; Lee HY Yonsei Med J; 1992 Sep; 33(3):232-9. PubMed ID: 1292247 [TBL] [Abstract][Full Text] [Related]
7. Tacrolimus improves the proteinuria remission in patients with refractory IgA nephropathy. Zhang Q; Shi SF; Zhu L; Lv JC; Liu LJ; Chen YQ; Zhang H; Wang HY Am J Nephrol; 2012; 35(4):312-20. PubMed ID: 22456060 [TBL] [Abstract][Full Text] [Related]
8. Control of hypertension with the angiotensin converting enzyme inhibitor captopril reduces glomerular proteinuria. Ruilope LM; Miranda B; Oliet A; Millet VG; Rodicio JL; Romero JC; Raij L J Hypertens Suppl; 1988 Dec; 6(4):S467-9. PubMed ID: 3071587 [TBL] [Abstract][Full Text] [Related]
9. Diagnosis and treatment of primary glomerular diseases. Membranous nephropathy, focal segmental glomerulosclerosis and IgA nephropathy. Deegens JK; Wetzels JF Minerva Urol Nefrol; 2005 Sep; 57(3):211-36. PubMed ID: 15986018 [TBL] [Abstract][Full Text] [Related]
10. [The effect of angiotensin-converting enzyme inhibitors on proteinuria in chronic glomerulonephritis]. Erley CM; Komini E; Nicaeus T; Braun N; Wolf S; Risler T Dtsch Med Wochenschr; 1994 Jan; 119(4):89-95. PubMed ID: 8299527 [TBL] [Abstract][Full Text] [Related]
11. The implications of focal segmental glomerulosclerosis in children with IgA nephropathy. Trimarchi H; Coppo R Pediatr Nephrol; 2020 Nov; 35(11):2043-2047. PubMed ID: 31773265 [TBL] [Abstract][Full Text] [Related]
12. Glucocorticoids in the treatment of patients with primary focal segmental glomerulosclerosis and moderate proteinuria. Huang J; Lin L; Xie J; Li X; Shen P; Pan X; Ren H; Chen N Clin Exp Nephrol; 2018 Dec; 22(6):1315-1323. PubMed ID: 29761241 [TBL] [Abstract][Full Text] [Related]
13. Focal segmental glomerulosclerosis in mild IgA nephropathy: a clinical-pathologic study. Weber CL; Rose CL; Magil AB Nephrol Dial Transplant; 2009 Feb; 24(2):483-8. PubMed ID: 18786972 [TBL] [Abstract][Full Text] [Related]
14. Long-term beneficial effects of angiotensin-converting enzyme inhibition in patients with nephrotic proteinuria. Praga M; Hernández E; Montoyo C; Andrés A; Ruilope LM; Rodicio JL Am J Kidney Dis; 1992 Sep; 20(3):240-8. PubMed ID: 1519604 [TBL] [Abstract][Full Text] [Related]
15. Remission of proteinuria in primary glomerulonephritis: we know the goal but do we know the price? Philibert D; Cattran D Nat Clin Pract Nephrol; 2008 Oct; 4(10):550-9. PubMed ID: 18725916 [TBL] [Abstract][Full Text] [Related]
16. The impact of sex in primary glomerulonephritis. Cattran DC; Reich HN; Beanlands HJ; Miller JA; Scholey JW; Troyanov S; Nephrol Dial Transplant; 2008 Jul; 23(7):2247-53. PubMed ID: 18182409 [TBL] [Abstract][Full Text] [Related]
17. Primary glomerulonephritis: an update on renal survival and determinants of progression. Moranne O; Watier L; Rossert J; Stengel B; QJM; 2008 Mar; 101(3):215-24. PubMed ID: 18245806 [TBL] [Abstract][Full Text] [Related]